West Pharmaceutical Services, Inc. Forecast, price target & analysts
West Pharmaceutical Services, Inc. Target price 2025 - Analyst rating & recommendation
West Pharmaceutical Services, Inc. Classifications & Recommendation:
West Pharmaceutical Services, Inc. Price Target
| Target Price | $293.00 |
| Price | $211.00 |
| Potential |
38.86%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target West Pharmaceutical Services, Inc. 2026 .
The average West Pharmaceutical Services, Inc. target price is $293.00.
This is
38.86%
register free of charge
$393.00
86.26%
register free of charge
$250.00
18.48%
register free of charge
|
|
| A rating was issued by 14 analysts: 10 Analysts recommend West Pharmaceutical Services, Inc. to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the West Pharmaceutical Services, Inc. stock has an average upside potential 2026 of
38.86%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.89 | 2.90 |
| 1.96% | 0.24% | |
| EBITDA Margin | 25.07% | 24.81% |
| 12.78% | 1.03% |
10 Analysts have issued a sales forecast West Pharmaceutical Services, Inc. 2025 . The average West Pharmaceutical Services, Inc. sales estimate is
This results in the following potential growth metrics:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 6.69 | 6.03 |
| 15.10% | 9.87% | |
| P/E | 35.02 | |
| EV/Sales | 5.17 |
6 Analysts have issued a West Pharmaceutical Services, Inc. forecast for earnings per share. The average West Pharmaceutical Services, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the West Pharmaceutical Services, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
West Pharmaceutical Services, Inc....
Current West Pharmaceutical Services, Inc. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Keybanc | Overweight ➜ Overweight | Unchanged | Feb 14 2025 |
| Citigroup | ➜ Buy | Initiated | Jan 08 2025 |
| B of A Securities | Buy ➜ Buy | Unchanged | Dec 13 2024 |
| Wolfe Research | ➜ Peer Perform | Initiated | Dec 13 2024 |
| UBS | Neutral ➜ Buy | Upgrade | Dec 12 2024 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Keybanc: Overweight ➜ Overweight
|
Feb 14 2025 |
|
Initiated
Citigroup: ➜ Buy
|
Jan 08 2025 |
|
Unchanged
B of A Securities: Buy ➜ Buy
|
Dec 13 2024 |
|
Initiated
Wolfe Research: ➜ Peer Perform
|
Dec 13 2024 |
|
Upgrade
UBS: Neutral ➜ Buy
|
Dec 12 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
